Veradermics, Incorporated · NYSE:MANE
Hollander David received 9,650 Veradermics, Incorporated shares as an award (Form 4)
Traded Sep 1, 2026 · Filed Sep 3, 2026
On Sep 1, 2026, Hollander David (Chief R&D Officer) received 9,650 Veradermics, Incorporated shares as an award, leaving 9,650 shares. Filed Sep 3, 2026 (Form 4).
- Awarded
- 9,650 shares
- Holding after
- 9,650 shares
- Trading plan
- No
- Role
- Chief R&D Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | Award | 9,650 | 9,650 | Direct |
Source
Related
- Veradermics, Incorporated
- Hollander David
- Veradermics, Incorporated shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Averill Master Fund, Ltd. · Aug 21, 2026
- Schedule 13D/A · Montanova Capital, LLC · Aug 21, 2026
- Form 4 · Durso Timothy August · Aug 18, 2026
- Form 4 · Waldman Reid Alexander · Aug 18, 2026